Assessing the economic value of maintained improvements in Type 1 diabetes management, in terms of HbA1c , weight and hypoglycaemic event incidence.
P McEwanH BennettK BolinLyndon Marc EvansK BergenheimPublished in: Diabetic medicine : a journal of the British Diabetic Association (2018)
Maintained reductions in HbA1c significantly alleviate the burden associated with Type 1 diabetes in the UK. Given the influence of weight and hypoglycaemia on health economic outcomes, they must also be key considerations when assessing the value of Type 1 diabetes technologies in clinical practice.
Keyphrases
- type diabetes
- clinical practice
- body mass index
- weight loss
- physical activity
- glycemic control
- risk factors
- weight gain
- healthcare
- public health
- mental health
- cardiovascular disease
- body weight
- insulin resistance
- life cycle
- cross sectional
- health information
- metabolic syndrome
- risk assessment
- adipose tissue
- human health